ABT-431, a D1 receptor agonist prodrug, has efficacy in Parkinson's disease.
Rascol O, Blin O, Thalamas C, Descombes S, Soubrouillard C, Azulay P, Fabre N, Viallet F, Lafnitzegger K, Wright S, Carter JH, Nutt JG.
Rascol O, et al. Among authors: fabre n.
Ann Neurol. 1999 Jun;45(6):736-41. doi: 10.1002/1531-8249(199906)45:6<736::aid-ana7>3.0.co;2-f.
Ann Neurol. 1999.
PMID: 10360765
Clinical Trial.